Nippon India Pharma Fund - Direct Plan - Growth Plan - Regular - Latest NAV [ ₹341.1323 ], Returns, Performance, Portfolio & Returns 2021

Nippon India Pharma Fund - Direct Plan - Growth Plan

  • highlight
  • highlight

Min amount: ₹1,000

Calculate Returns

20 yrs
₹1,000 invested monthly becomes
0 in a period of 20 years

Fund Summarystar

PeriodReturns(per year)
10 Years--
5 Years17.87%
3 Years25.45%
1 Year41.76%
6 Months27.97%
Fund Details
RiskVery High Risk
Fund TypeSector - Healthcare
Exit Load1% for 31 Days

More about this fundstar

Top HoldingsWeightage
Sun Pharmaceuticals Industries Ltd10.65%
Divi's Laboratories Ltd10.04%
Dr Reddy's Laboratories Ltd8.3%
Apollo Hospitals Enterprise Ltd6.76%
Cipla Ltd6.69%
Gland Pharma Ltd5.84%
Aurobindo Pharma Ltd5.78%
Lupin Ltd5.75%
Fortis Healthcare Ltd5.43%
Narayana Hrudayalaya Ltd4.7%

About Nippon India Pharma Fund

Nippon India Pharma Fund is an open-ended equity scheme that primarily invests in equity and equity-related or fixed income securities of pharmaceutical companies and other allies in order to generate consistent returns. The scheme focuses on important segments of the sector, such as domestic and international business & CRAMS, including the deep value as well as high-growth pharma business.

Pros and Cons of Nippon India Pharma Fund

Nippon India Pharma Fund does not impose a lock-in period on your investments. As per the historic data, the three-year and five-year returns are higher than the category average returns. However, the risk-adjusted returns have not been up to the other schemes in the category. An exit load is chargeable if you redeem units before one month from the date of allotment.

Fund Information and Statistics

i) Inception/Launch Date Nippon India Pharma Fund was rolled out on 5 June 2004.

ii) Risk Level The scheme comes with a high risk profile as the investments are primarily allocated towards equity and equity-related securities of pharma companies and associates.

iii) Redemption No lock-in period applicable to the investments made, so you can redeem the units at any time. However, redeeming units before completing a month from the date of allotment will result in adding exit load.

iv) Fund Manager Mr Sailesh Raj Bhan is the current Fund Manager for Nippon India Pharma Fund.

v) Entry/Exit Load According to SEBI’s circular dated 30 June 2009, entry load is not chargeable on purchase of mutual fund units. An exit load of 1% is chargeable when you redeem units within one month from the date of allotment. If you redeem after completing one month, no exit load is charged.

About Nippon India Mutual Fund

Nippon India Mutual Funds (NIMF), a leading mutual fund company in India, registered itself as a mutual fund company with SEBI on 30 June 1995. Nippon Life Insurance Company (NLI) is the sponsor and Nippon Life India Trustee Limited (NLITL) is the trustee. The company has around 91.19 lakh folios with average assets under management (AAUM) worth Rs.1,80,060.69 crore as of 30 June 2020.

Customer Reviewsstar

  • " Great investing experience! Contacted the support with queries.. Got immediate response and all my doubts clarified. Will definitely recommend ClearTax to friends "

    IT Developer, Bangalore
  • " I am new to investments and got all the information I need on your website. The suggestions for mutual fund investments and tax savings are great. "

    Software Engineer, Indore
  • " Investing through ClearTax is super easy and simple. It is extremely helpful for investors with less finance knowledge. "

    Campus Manager, Bangalore

Invest Now in 3 Easy Stepsstar

  • 1
  • 2
  • 3

Why ClearTax Invest?

  • checkOur experts do all the research and offer only the BEST mutual funds
  • checkTrusted by Over 25 Lakh Indians
  • checkInvest in just 5 minutes
  • checkNo paperwork required
  • checkSimple and easy to use

Frequently Asked Questions

  • Read More

Min amount: ₹1,000

Calculate Returns

20 yrs
₹1,000 invested monthly becomes
0 in a period of 20 years
Very High Risk

All investments come with risk. Risk is the volatility or fluctuation in the price (and returns) of the investment. Usually,

  • High Risk = High possible returns
  • Low Risk = Stable, relatively lower returns